United States

PatientsLikeMe, inVentiv Health partner to accelerate research

Wednesday, June 19, 2013 01:58 PM

CRO inVentiv Health is partnering with online patient network PatientsLikeMe, which has 200,000 members who share information and experiences on more than 1,500 different diseases and conditions, to bring people more quickly into medical research and clinical trials.  

More... »

CollabRx, University of Chicago collaborate

Wednesday, June 19, 2013 01:50 PM

CollabRxa data analytics, focused on informing clinical decision making in molecular medicine, is collaborating with the thoracic oncology program at the University of Chicago Medical Center, a cancer treatment center with clinical and translational research programs in cancer genetics and therapeutics.

More... »

Imprimis Pharmaceuticals acquires Buderer intellectual property assets

Tuesday, June 18, 2013 10:56 AM

Imprimis Pharmaceuticals has acquired the intellectual property (IP) rights related to proprietary innovations from the compounding pharmacy operations of Ohio-based Buderer Drug, a compounding pharmacy member of PCCA.

More... »

Cempra outlines steps for regulatory approval of solithromycin

Monday, June 17, 2013 02:07 PM

Cempra, a clinical-stage pharmaceutical company developing differentiated antibiotics to meet critical medical needs in the treatment of bacterial infections, has described the steps expected for regulatory approval for solithromycin for community-acquired bacterial pneumonia (CABP).  This path is a result of a dialogue and end-of-phase II meeting with the FDA.

More... »

Parexel names Ingo Bank senior vice president, CFO

Monday, June 17, 2013 02:03 PM

Global CRO Parexel International has named Ingo Bank senior vice president, and he will become chief financial officer September after fiscal year-end audited financial statements are filed. 

More... »

AMRI names business development director

Monday, June 17, 2013 02:00 PM

AMRI named Susan Collins director of business development for North American Discovery Services, reporting to Christopher Conway, vice president of business development. Collins is responsible for leading a team promoting AMRI's global drug discovery services.

More... »

Johnson & Johnson to acquire Aragon Pharmaceuticals

Monday, June 17, 2013 01:53 PM

Johnson & Johnson has announced a definitive agreement to acquire Aragon Pharmaceuticals, a privately-held pharmaceutical discovery and development company focused on drugs to treat hormonally-driven cancers.

More... »

Catalent Pharma Solutions expands manufacturing facility

Friday, June 14, 2013 01:41 PM

Catalent Pharma Solutions, a global drug delivery technology and advanced supply solutions company, has announced an expansion of its controlled release drug manufacturing facility in Winchester, Ky. Catalent will invest nearly $35 million to expand the 100,000-square-foot facility by almost 80,000 square feet of modern manufacturing space, and will add as many as 90 new employees.

Opened in 1992, Catalent's Winchester facility focuses on advanced oral controlled-release drug formulation and manufacturing, and has launched over 100 products for Catalent's pharmaceutical and consumer health customers.

More... »

Northwest Biotherapeutics initiates phase I/II trial

Friday, June 14, 2013 01:38 PM

Northwest Biotherapeutics, a developer of non-toxic DCVax personalized immune therapies for solid tumor cancers, has announced  its 60-patient, phase I/II clinical trial of DCVax-Direct for all inoperable solid tumor cancers has been initiated at The University of Texas MD Anderson Cancer Center.

More... »

MEI Pharma appoints Nick Glover to board of directors

Friday, June 14, 2013 01:35 PM

MEI Pharma, an oncology company focused on the clinical development of novel therapies for cancer, has appointed Nick Glover, Ph.D., to its board of directors, increasing the board to seven members, including six independent directors.

More... »